Why Indian Units Of Pharma MNCs Are Emerging As A Safe Bet For Investors
Rows of glass vials in a biologics laboratory. Photographer: Mikael Sjoberg/Bloomberg

Why Indian Units Of Pharma MNCs Are Emerging As A Safe Bet For Investors

Listed subsidiaries of foreign drugmakers have outperformed their domestic peers and the benchmark Nifty Pharma Index this year on the back of new product launches and the government’s push for aff...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.